In particular, this transmembrane receptor has been suggested as a molecular therapeutic target for glioblastoma, with overexpression mainly due to endothelial cells of angiogenic phenotype and associated pro-tumor macrophages, both of which are linked to an unfavorable prognosis [6]. The gene discussed is NRP1; the disease is glioblastoma.